Investigators Assess Infection Risk with RA Biologics
Ustekinumab Has Longer Efficacy Duration than TNFIs for Plaque Psoriasis
When Starting Biologics for RA, Disease Severity Predicts Likelihood of Remission
Rheumatology Research Foundation
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
ACR/ARP Annual Meeting
Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.
ACR/ARP Meeting Abstracts
Browse and search abstracts from the ACR/ARP Annual Meetings going back to 2012.